Skip to main content
Fig. 7 | Journal of Nanobiotechnology

Fig. 7

From: Extracellular matrix modulating enzyme functionalized biomimetic Au nanoplatform-mediated enhanced tumor penetration and synergistic antitumor therapy for pancreatic cancer

Fig. 7

In vivo therapeutic efficacy in BxPC3 tumor-bearing mice. a Treatment schedule for the antitumor experiment. b Tumor growth curves during different treatments (n = 6). c Images of the excised tumors on Day 21. d Weights of the excised tumors on Day 21. e Survival rate of BxPC3 tumor-bearing mice after receiving different treatments in 60 days (n = 6). f Serum ALT, AST, BUN and CR levels in tumor-bearing mice after intervention (n = 3). g H&E, TUNEL and Ki67 staining of tumors after mice received different treatments

Back to article page

Journal of Nanobiotechnology

ISSN: 1477-3155

Contact us